MidCap Provides $160MM Senior Secured Credit Facility to Akorn Pharmaceuticals
MidCap Financial provided a $160 million senior revolving credit facility to Akorn, a specialty pharmaceutical company. The credit facility refinanced the company’s prior credit facility to facilitate the company’s emergence from its Chapter 11 filing.
October 12, 2020
Akorn Pharmaceuticals | MidCap Financial
Ellie Delany